Mirae Asset Global Investments’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9K Buy
2,979
+931
+45% +$3.72K ﹤0.01% 1467
2025
Q1
$6.92K Sell
2,048
-93
-4% -$314 ﹤0.01% 1498
2024
Q4
$11.2K Buy
+2,141
New +$11.2K ﹤0.01% 1501